Ignite Creation Date:
2024-05-05 @ 9:41 PM
Last Modification Date:
2024-10-26 @ 10:08 AM
Study NCT ID:
NCT00943943
Status:
COMPLETED
Last Update Posted:
2017-03-29
First Post:
2009-07-20
Brief Title:
Granulocyte-colony Stimulating Factor G-CSF and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia AML With FLT3 Mutations
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Organization Data
Organization:
MD Anderson Cancer Center
Class:
OTHER
Study ID:
2008-0501
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
MD Anderson Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Georgia Institute of Technology | OTHER |
| Bayer | INDUSTRY |
| Genzyme a Sanofi Company | INDUSTRY |
| Amgen | INDUSTRY |
| National Cancer Institute NCI | NIH |